Serological Screening for Infectious Diseases

Sera samples were tested for anti-HCV using automated CMIA (Lai Bo Biotechnology, Inc. Jinan, China). The samples were considered positive when the results exceeded the cutoff (s/co) value of 1.00 (according to the manufacturer’s recommendations). The positive samples were subsequently tested for HCV core antigen (HCV cAg; Lai Bo Biotechnology, Inc. Jinan, China), hepatitis B surface antigen (HBsAg, SYSMEX CORPORATION, Janpan), HIV antigen + antibody (Ag + Ab; SYSMEX CORPORATION, Janpan), syphilis antibody (anti-TP; Lai Bo Biotechnology, Inc. Jinan, China), anti-hepatitis A virus (HAV) IgM, and anti-hepatitis E virus (HEV) IgM (Xiamen Innodx Biotech Co., Ltd., Xiamen, China).

Free full text: Click here

Xu M., Liu F., Zhao Q., Zhou Y., Zhuang Y, & Ji M. (2023). Seroprevalence of hepatitis C virus in Jinan, China, 2008–2020. European Journal of Medical Research, 28, 112.

Publication 2023

Anti hcv Anti igm Antibody Antigen Hbsag Hepatitis a virus Hepatitis e virus Hiv antibody Sera Syphilis

Corresponding Organization : Shandong First Medical University

Other organizations : Shandong University

Top 5 similar protocols

Variable analysis

independent variables

Sera samples tested for anti-HCV using automated CMIA

dependent variables

Anti-HCV results exceeding the cutoff (s/co) value of 1.00
HCV core antigen (HCV cAg)
Hepatitis B surface antigen (HBsAg)
HIV antigen + antibody (Ag + Ab)
Syphilis antibody (anti-TP)
Anti-hepatitis A virus (HAV) IgM
Anti-hepatitis E virus (HEV) IgM

control variables

Cutoff (s/co) value of 1.00 for anti-HCV results (according to the manufacturer's recommendations)

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!